108 related articles for article (PubMed ID: 10193716)
1. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy.
Lee CW; Lee JH; Kim JJ; Park SW; Hong MK; Kim ST; Lim TH; Park SJ
J Am Coll Cardiol; 1999 Apr; 33(5):1196-202. PubMed ID: 10193716
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure.
Lee CW; Lee JH; Lim TH; Yang HS; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
Circulation; 2001 Jun; 103(23):2784-7. PubMed ID: 11401932
[TBL] [Abstract][Full Text] [Related]
3. Effects of heart transplantation on cerebral metabolic abnormalities in patients with congestive heart failure.
Lee CW; Lee JH; Yang HS; Lim KH; Ahn JM; Hong MK; Park SW; Park SJ; Song MG; Kim JJ
J Heart Lung Transplant; 2006 Mar; 25(3):353-5. PubMed ID: 16507431
[TBL] [Abstract][Full Text] [Related]
4. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy.
Shim TS; Lee JH; Kim SY; Lim TH; Kim SJ; Kim DS; Kim WD
Chest; 2001 Nov; 120(5):1506-13. PubMed ID: 11713127
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
8. Positive correlations between cerebral choline and renal dysfunction in chronic renal failure.
Sasaki O; Hattori N; Nakahama H; Inoue N; Nakamura S; Inenaga T; Kohno S; Sawada T; Kawano Y
Neuroradiology; 2006 May; 48(5):300-6. PubMed ID: 16586119
[TBL] [Abstract][Full Text] [Related]
9. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.
Pouwels PJ; Frahm J
Magn Reson Med; 1998 Jan; 39(1):53-60. PubMed ID: 9438437
[TBL] [Abstract][Full Text] [Related]
10. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy.
Kumar A; Thomas A; Lavretsky H; Yue K; Huda A; Curran J; Venkatraman T; Estanol L; Mintz J; Mega M; Toga A
Am J Psychiatry; 2002 Apr; 159(4):630-6. PubMed ID: 11925302
[TBL] [Abstract][Full Text] [Related]
11. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
12. Early glial activation precedes neurodegeneration in the cerebral cortex after SIV infection: a 3D, multivoxel proton magnetic resonance spectroscopy study.
Wu WE; Babb JS; Tal A; Kirov II; George AE; Ratai EM; Gonzalez RG; Gonen O
HIV Med; 2015 Jul; 16(6):381-7. PubMed ID: 25689120
[TBL] [Abstract][Full Text] [Related]
13. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
[TBL] [Abstract][Full Text] [Related]
14. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
15. Dialysis and transplantation affect cerebral abnormalities of end-stage renal disease.
Michaelis T; Videen JS; Linsey MS; Ross BD
J Magn Reson Imaging; 1996; 6(2):341-7. PubMed ID: 9132100
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
[TBL] [Abstract][Full Text] [Related]
17. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
18. Metabolic change in the right dorsolateral prefrontal cortex and its correlation with symptom severity in patients with generalized anxiety disorder: Proton magnetic resonance spectroscopy at 3 Tesla.
Moon CM; Kang HK; Jeong GW
Psychiatry Clin Neurosci; 2015 Jul; 69(7):422-30. PubMed ID: 25611853
[TBL] [Abstract][Full Text] [Related]
19. Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Geissler A; Fründ R; Kohler S; Eichhorn HM; Krämer BK; Feuerbach S
Radiology; 1995 Mar; 194(3):693-7. PubMed ID: 7862964
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of linear nevus sebaceus syndrome.
Kruse B; Pouwels PJ; Christen HJ; Frahm J; Hanefeld FA
Pediatr Neurol; 1998 Feb; 18(2):176-80. PubMed ID: 9535307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]